Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa
about
Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania.Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa.Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcomeMean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings.Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.Reverse transcriptase drug resistance mutations in HIV-1 subtype C infected patients on ART in Karonga District, Malawi.Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa.HIV treatment and care in resource-constrained environments: challenges for the next decade.In-house HIV-1 RNA real-time RT-PCR assays: principle, available tests and usefulness in developing countries.Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.Antiretroviral treatment changes in adults from Côte d'Ivoire: the roles of tuberculosis and pregnancy.Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.Antiretroviral drug resistance among antiretroviral-naïve persons with recent HIV infection in Thailand.Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia.
P2860
Q33479343-EC60C317-EE0E-4AB9-A891-96FC166135A3Q33872061-076E0634-F837-49EB-804F-38BA62B42F5DQ34292437-82D90DF1-A436-4EDF-A707-C07F2ECDA5A4Q34320076-C359BA37-5A56-43D9-80B4-592F2CCC1584Q34630565-60DABE4B-D012-459C-8562-A0A714B0210FQ35548657-AE23B914-A4D0-4EC5-8473-50E161A9D97DQ35575725-3B8A7207-AFAD-4E6C-8FAA-1F9902F4FCB5Q36386806-33365E16-17E9-4420-B3B0-AF9BF6406159Q37266495-D19CD203-6A30-48BA-84AA-42FE407C6B5FQ37343891-6A0F198D-912A-4553-8ED6-87290140D410Q37483442-4E747EF1-CDF6-4599-B402-DAD3A8C9D596Q37578947-ED7D0B77-CC5F-4A19-BA40-CE2EEFEA466FQ37605850-FE3C5FB8-CA15-4786-8C65-259CDAE4780EQ39311484-5FA365F1-3817-480C-9BE9-F5277F0D12C9Q46654737-2E43E9D9-CA78-478A-AB2E-0BE4ED7C1067Q55519161-1B7B6744-30EA-4824-97A1-1E508957F93C
P2860
Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Impact of genotypic drug resis ...... adults on HAART in West Africa
@ast
Impact of genotypic drug resis ...... adults on HAART in West Africa
@en
type
label
Impact of genotypic drug resis ...... adults on HAART in West Africa
@ast
Impact of genotypic drug resis ...... adults on HAART in West Africa
@en
prefLabel
Impact of genotypic drug resis ...... adults on HAART in West Africa
@ast
Impact of genotypic drug resis ...... adults on HAART in West Africa
@en
P2093
P2860
P1433
P1476
Impact of genotypic drug resis ...... adults on HAART in West Africa
@en
P2093
Catherine Seyler
Christiane Adjé-Touré
Eugène Messou
François Rouet
Monica Nolan
Nicole Dakoury-Dogbo
Siaka Toure
P2860
P304
P356
10.1097/QAD.0B013E3281C615DA
P407
P577
2007-05-01T00:00:00Z